Skip to main content

Gary Gibbons

Joining Forces Against Sickle Cell Disease and HIV Infection

Posted on by

Gates Collaboration Telebriefing
The NIH and the Bill and Melinda Gates Foundation, Seattle, will invest at least $200 million over the next four years to develop affordable gene-based cures globally for sickle cell disease and HIV infection. The announcement of this timely collaboration was made during a late-morning telebriefing at NIH on October 23, 2019. Here, I met with two of my fellow participants on the call: Gary Gibbons (left), director of NIH’s Heart, Lung, and Blood Institute; and Trevor Mundel, (middle), president of the Gates Foundation’s global health efforts. Also joining the telebriefing remotely by phone were Tony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases; and Matishidiso Moeti, director of the World Health Organization’s Regional Office for Africa. Credit: NIH

Testifying Before House Subcommittee

Posted on by

On April 2, 2019, I testified before the House Labor/HHS Appropriations Subcommittee on NIH’s budget for Fiscal Year 2020. Here I am waiting for the hearing to start with my colleagues (left to right) Gary Gibbons, director of the National Heart, Lung, and Blood Institute; Diana Bianchi, director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; and Anthony Fauci, director of National Institute of Allergy and Infectious Diseases. Credit: NIH